ChemicalBook > Product Catalog >API >Respiratory Drugs >Asthma drugs >Pranlukast

Pranlukast

Pranlukast Structure
CAS No.
103177-37-3
Chemical Name:
Pranlukast
Synonyms
Onon;rs411;Ultair;ono1078;Prenast;Pranlukas;ONO-RS-411;emihydrate;PRANLUKAST;ONO-RS-411-01
CBNumber:
CB3271355
Molecular Formula:
C27H23N5O4
Molecular Weight:
481.5
MOL File:
103177-37-3.mol
MSDS File:
SDS
Modify Date:
2024/6/6 17:55:34

Pranlukast Properties

Melting point 236-238°C
Density 1.374±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 25 mg/ml)
form solid
pka 4.96±0.10(Predicted)
color White
Merck 14,7710
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
CAS DataBase Reference 103177-37-3(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319-H413
Precautionary statements  P501-P273-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Hazard Codes  F,C
Risk Statements  11-34
Safety Statements  16-26-36/37/39-45
RTECS  CV5647500
HS Code  2934.99.4400
Toxicity LD50 in male mice (mg/kg): >1000 i.v. (Toda)
NFPA 704
0
2 0

Pranlukast price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TCI Chemicals (India) P2115 Pranlukast 103177-37-3 25MG ₹2600 2022-05-26 Buy
TCI Chemicals (India) P2115 Pranlukast 103177-37-3 100MG ₹8100 2022-05-26 Buy
Product number Packaging Price Buy
P2115 25MG ₹2600 Buy
P2115 100MG ₹8100 Buy

Pranlukast Chemical Properties,Uses,Production

Description

Pranlukast, a novel chromone derivative, was introduced in Japan for the treatment of bronchial asthma and allergic diseases. Pranlukast is a highly potent, selective and competitive antagonist of peptidoleukotrienes with high affinity for the LTD4 receptor. In patients with bronchial asthma, pranlukast was reported to induce significant improvement in both immediate and late asthmatic response induced by antigen. Pranlukast is also being evaluated clinically for the treatment of perennial allergic rhinitis, pediatric asthma, and cutaneous pruritus in dialysis patients. The therapeutic potential of pranlukast in managing irritable bowel syndrome has been suggested.

Chemical Properties

Off-white solid

Uses

Labeled Pranlukast, intended for use as an internal standard for the quantification of Pranlukast by GC- or LC-mass spectrometry.

Biological Activity

Selective cysteinyl leukotriene receptor 1 (CysLT 1 ) antagonist (IC 50 values are ~ 4-7 and 3620 nM for CysLT 1 and CysLT 2 respectively). Inhibits contraction of airway smooth muscle, microvascular leakage into airways and eosinophil infiltration. Can decrease symptoms of bronchial asthma.

Pranlukast Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 273)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Thykn India International 08048372611Ext 128 Mumbai, India 22 58 Inquiry
Bioorganics & Applied Materials Pvt. Ltd. 08048250473Ext 567 Karnataka, India 46 58 Inquiry
RA Chem Pharma Limited 07093802565 Hyderabad, India 2 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Shagun Pharmaceuticals 91-731-2575029 Madhya Pradesh, India 193 58 Inquiry
TCI Chemicals (India) Pvt. Ltd. 1800 425 7889 New Delhi, India 6778 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry

Pranlukast Spectrum

PRANLUKAST 4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1-benzopyranh benzamide,n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutox emihydrate ONO-RS-411 ONO-RS-411-01 N-[4-keto-2-(2H-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide N-[4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzam BenzaMide,N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)- N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-benzamide 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran Pranlukast-d4 Onon Pranlukast (ONO 1078) ono1078 rs411 N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide, ONO-1078, ONO-RS-411, Onon, 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide Pranlukast > Pranlukast RS Pranlukas EP/GMP/FDA Pranlukast Pranlukast USP/EP/BP Pranlukast (1.0mg/ml in DMSO) Pranlukast (10mM in DMSO) Pranlukast D4Q: What is Pranlukast D4 Q: What is the CAS Number of Pranlukast D4 Q: What is the storage condition of Pranlukast D4 Q: What are the applications of Pranlukast D4 Prenast Ultair 103177-37-3 C27H23N5O4 API Aromatics Heterocycles Inhibitors Intermediates & Fine Chemicals Pharmaceuticals Antiasthmatic